QT
HRTX icon

Quantbot Technologies’s Heron Therapeutics HRTX Stock Holding History

Quantbot Technologies’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-10,992
Closed -$11.3K – 1761
2023
Q3 		$11.3K Buy
+10,992
New +$15.6K ﹤0.01% 1398
2023
Q1 		– Sell
-33,100
Closed -$82.8K – 1766
2022
Q4 		$82.8K Sell
33,100
-61,298
-65% -$197K 0.01% 1190
2022
Q3 		$398K Buy
94,398
+25,846
+38% +$101K 0.03% 656
2022
Q2 		$191K Buy
68,552
+50,314
+276% +$202K 0.02% 936
2022
Q1 		$104K Buy
+18,238
New +$133K 0.01% 1038
2021
Q2 		– Sell
-3,771
Closed -$61K – 1617
2021
Q1 		$61K Buy
+3,771
New +$67.2K 0.01% 972
2020
Q1 		– Sell
-5,333
Closed -$125K – 1105
2019
Q4 		$125K Buy
5,333
+4,333
+433% +$95.9K 0.01% 766
2019
Q3 		$18K Buy
+1,000
New +$18.4K ﹤0.01% 1118
2018
Q3 		– Sell
-29,379
Closed -$1.14M – 1379
2018
Q2 		$1.14M Buy
29,379
+25,136
+592% +$800K 0.08% 367
2018
Q1 		$117K Buy
+4,243
New +$96.3K 0.01% 810
2017
Q4 		– Sell
-6,395
Closed -$103K – 1320
2017
Q3 		$103K Sell
6,395
-6,088
-49% -$95.5K 0.01% 836
2017
Q2 		$172K Buy
12,483
+12,024
+2,620% +$174K 0.02% 698
2017
Q1 		$6K Sell
459
-6,432
-93% -$89K ﹤0.01% 1067
2016
Q4 		$90K Buy
+6,891
New +$108K 0.01% 732
2016
Q1 		– Sell
-170
Closed -$4K – 1261
2015
Q4 		$4K Buy
+170
New +$4.55K ﹤0.01% 1018

Other funds holding HRTX

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Quantbot Technologies's HRTX Position: Q4 2023 in Review

Quantbot Technologies sold out of Heron Therapeutics (HRTX) in Q4 2023, closing a stake of 10,992 shares — an estimated $11.3K sold.

Quantbot Technologies first reported a position in HRTX in Q4 2015 and held it in 15 quarters. The position peaked at $1.14M in Q2 2018. 151 funds tracked by Wall St. Rank hold HRTX as of Q4 2023.

  • Quantbot Technologies reported no remaining Heron Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Quantbot Technologies sold 10,992 Heron Therapeutics shares in Q4 2023, an estimated $11.3K.
  • Quantbot Technologies first reported a position in Heron Therapeutics in Q4 2015 and held it in 15 quarters.
  • Quantbot Technologies's Heron Therapeutics position peaked at $1.14M in Q2 2018.
  • 151 funds tracked by Wall St. Rank held Heron Therapeutics as of Q4 2023.

Based on Quantbot Technologies's 13F filing for Q4 2023, filed 14 Feb 2024.